Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stock Options of Board

Way beyond my expertise, but my understanding is that many private equity/VC funds pay the 15% tax rate on both cap gains and ordinary income ("carried interest").

I've no idea if Swartz's fund has losses against which to offset PTSC gains, but if they do, it would be logical to sell enough PTSC to soak up those losses.

Share
New Message
Please login to post a reply